Cystic fibrosis (CF) is a rare genetic disorder that affects one in 3,900 live births. There are approximately 30,000...

On June 7, 2022, the Centers for Medicare and Medicaid Services (CMS) released the 2021 Part C and Part D Program Audit...

Elixir announced the launch of a specialty generic medication enhancement to our suite of solutions effective June 1,...

With the growing specialty drug pipeline that is contributing to nearly half of overall drug spend, we have been...

The role of the Clinical Account Executive (CAE) at Elixir is a very important one for helping clients identify...

Approximately 40% of Americans will be diagnosed with some type of cancer in their lifetime. Many cancer treatments...

This February, Centers for Medicare and Medicaid Services (CMS) announced an update to the Medicare Communications and...

In our four-part series on specialty drug management, we have covered the importance of monitoring drugs before FDA...

Diabetes is a growing concern in the United States, with 35 million individuals impacted by type 2 diabetes mellitus...

There is no cure for the debilitating disease multiple sclerosis (MS); however, there are treatments that can slow...